上(shàng)海麥克林生(shēng)化(huà)科技有限公司是一(yī)家高端研發用試劑産品的制造商(shāng)與供應商(shāng),旨在為(wèi)全球科技事(shì)業和工業領域客戶提供系統的産品資源及配套技術服務(wù)。
麥克林成立于2013年,公司總部設在上(shàng)海浦東新(xīn)區張江高科技園區,在美國加州、北京、廣州、成都、武漢、鄭州等主要城市(shì)設立有分(fēn)公司和辦事(shì)處,可為(wèi)全球客戶提供便捷全方位的服務(wù)。
麥克林事(shì)業朝氣蓬勃,在上(shàng)海化(huà)工園區設有20000平方米的生(shēng)産研發基地和龐大的倉儲物流中心,憑着一(yī)支富有創造天賦的專業團隊,新(xīn)技術、新(xīn)産品層出不窮。 目前,麥克林産品已達30000 多種,并呈持續增長态勢。産品包括通用試劑、藥物合成試劑、手性化(huà)合物、催化(huà)劑及配體(tǐ)、分(fēn)析試劑、生(shēng)物試劑等。麥克林的柔性生(shēng)産線能(néng)夠快(kuài)速提供小批量、多品種的産品,可以滿足實驗室研發、中試乃至規模化(huà)生(shēng)産需要。
麥克林秉承“商(shāng)德唯信、利末義本”的經營理(lǐ)念,緻力于與化(huà)學、醫(yī)藥、分(fēn)析、食品、能(néng)源、材料等領域的客戶建立互信、長久的合作(zuò)關(guān)系,為(wèi)實現(xiàn)“服務(wù)于全球的科技現(xiàn)代化(huà),為(wèi)人(rén)類科技事(shì)業繁榮提供營養品及催化(huà)劑”的使命而不懈努力!
貨号 | 項目中文名稱 | 項目英文名稱 | 項目規格 | 包裝規格 | 牌價 | 銷售價格 | CAS号 | 分(fēn)子(zǐ)式 | 分(fēn)子(zǐ)量 |
---|---|---|---|---|---|---|---|---|---|
S854315-100mg | (5aS,10bR)-5a,10b-Dihydro-2-(2,4,6-trimethylphenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate | (5aS,10bR)-5a,10b-Dihydro-2-(2,4,6-trimethylphenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate | ≥98%,99%e.e. | 100mg | 1550 | 1240 | 1061311-82-7 | C21H22BF4N3O | 419.2 |
S854315-500mg | (5aS,10bR)-5a,10b-Dihydro-2-(2,4,6-trimethylphenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate | (5aS,10bR)-5a,10b-Dihydro-2-(2,4,6-trimethylphenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate | ≥98%,99%e.e. | 500mg | 6248 | 4998.4 | 1061311-82-7 | C21H22BF4N3O | 419.2 |
R854316-100mg | (5aR,10bS)-5a,10b-Dihydro-2-(2,3,4,5,6-pentafluorophenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate | (5aR,10bS)-5a,10b-Dihydro-2-(2,3,4,5,6-pentafluorophenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate | ≥98%,99%e.e. | 100mg | 1813 | 1450.4 | 872143-57-2 | C18H11F5N3O BF4 | 467.1 |
R854316-500mg | (5aR,10bS)-5a,10b-Dihydro-2-(2,3,4,5,6-pentafluorophenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate | (5aR,10bS)-5a,10b-Dihydro-2-(2,3,4,5,6-pentafluorophenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate | ≥98%,99%e.e. | 500mg | 7218 | 5774.4 | 872143-57-2 | C18H11F5N3O BF4 | 467.1 |
S854317-100mg | (5aS,10bR)-5a,10b-Dihydro-2-(2,3,4,5,6-pentafluorophenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate | (5aS,10bR)-5a,10b-Dihydro-2-(2,3,4,5,6-pentafluorophenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate | ≥98%,99%e.e. | 100mg | 1813 | 1450.4 | 740816-14-2 | C18H11F5N3O BF4 | 467.1 |
S854317-500mg | (5aS,10bR)-5a,10b-Dihydro-2-(2,3,4,5,6-pentafluorophenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate | (5aS,10bR)-5a,10b-Dihydro-2-(2,3,4,5,6-pentafluorophenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate | ≥98%,99%e.e. | 500mg | 7218 | 5774.4 | 740816-14-2 | C18H11F5N3O BF4 | 467.1 |
S854318-50mg | 1,1'-[(5aS,8aS,14aS)-5a,6,7,8,8a,9-Hexahydro-5H-[1]benzopyrano[3,2-d]xanthene-1,13-diyl]bis[1,1-di(3,5-dimethylphenyl)phosphine] | 1,1'-[(5aS,8aS,14aS)-5a,6,7,8,8a,9-Hexahydro-5H-[1]benzopyrano[3,2-d]xanthene-1,13-diyl]bis[1,1-di(3,5-dimethylphenyl)phosphine] | ≥95%,99%e.e. | 50mg | 1937 | 1549.6 | NONE6475 | C52H54O2P2 | 772.9 |
S854318-100mg | 1,1'-[(5aS,8aS,14aS)-5a,6,7,8,8a,9-Hexahydro-5H-[1]benzopyrano[3,2-d]xanthene-1,13-diyl]bis[1,1-di(3,5-dimethylphenyl)phosphine] | 1,1'-[(5aS,8aS,14aS)-5a,6,7,8,8a,9-Hexahydro-5H-[1]benzopyrano[3,2-d]xanthene-1,13-diyl]bis[1,1-di(3,5-dimethylphenyl)phosphine] | ≥95%,99%e.e. | 100mg | 3231 | 2584.8 | NONE6475 | C52H54O2P2 | 772.9 |
S854319-25mg | (4S)-2-[(1R)-7'-(Diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-inden]-7-yl]-4,5-dihydro-4-(phenylmethyl)oxazole | (4S)-2-[(1R)-7'-(Diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-inden]-7-yl]-4,5-dihydro-4-(phenylmethyl)oxazole | ≥95%,99%e.e. | 25mg | 1788 | 1430.4 | NONE6476 | C39H34NOP | 563.7 |
S854319-100mg | (4S)-2-[(1R)-7'-(Diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-inden]-7-yl]-4,5-dihydro-4-(phenylmethyl)oxazole | (4S)-2-[(1R)-7'-(Diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-inden]-7-yl]-4,5-dihydro-4-(phenylmethyl)oxazole | ≥95%,99%e.e. | 100mg | 5366 | 4292.8 | NONE6476 | C39H34NOP | 563.7 |